col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


83 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Expert Review of Anti-infective Therapy
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―15 Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial Nazanin Majidi, Effat Bahadori, Soheila Shekari, Maryam Gholamalizadeh, Shirin Tajaddod, Marjan Ajami, et al. (+10)
2 [GO] 2022―Jul―15 The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose David Luque Paz, Pierre Sesques, Florent Wallet, Emmanuel Bachy, Florence Ader
3 [GO] 2022―Jul―05 Ivermectin Role in COVID-19 Treatment (IRICT): single center, adaptive, randomized, double-blind, placebo controlled, clinical trial Ahmed Hanei Elshafie, Hozaifa Khalil Elsawah, Mohamed Hammad, Eman Mohamed Sweed, Ahmed Salah Seif, Muhammad Mostafa Abdel Ghaffar, et al. (+3)
4 [GO] 2022―Jul―04 The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Chih-Cheng Lai, Wang-Chun Chen, Ching-Yi Chen, Yu-Feng Wei
5 [GO] 2022―May―26 Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava, Abdelwahab Omri
6 [GO] 2022―May―16 How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review Qian Wang, Xing Wu, Qunying Mao, Fan Gao, Mingchen Liu, Ziyang Song, et al. (+2)
7 [GO] 2022―May―13 Outpatient treatment options to address the SARS-CoV-2 variant Omicron Matthew W. McCarthy
8 [GO] 2022―Apr―22 False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews Yu-Pei Yang, Li-Li Huang, Shuang-jun Pan, Dan Xu, Zhu Liduzi Jiesisibieke, Tao-Hsin Tung
9 [GO] 2022―Apr―12 Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2? Jairo Azócar-Gallardo, Alex Ojeda-Aravena, Jorge Carrizo Largo, Claudio Hernández-Mosqueira
10 [GO] 2022―Feb―25 Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): amulticenter real-world evidence Yahya A. Mohzari, Ahmad Alamer, Majda Alattas, Ahmed A. Alrashed, Nura A. Alshehab, Turkiah K. Alkhaldi, et al. (+23)
11 [GO] 2022―Jan―29 Containment strategies for COVID-19 in India: lessons from the second wave Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal
12 [GO] 2022―Jan―28 COVID-19 and Vitamin D (Co-VIVID Study): a systematic review and meta-analysis of randomized controlled trials Seshadri Reddy Varikasuvu, Balachandar Thangappazham, Alekya Vykunta, Pragathi Duggina, Munikumar Manne, Hemanth Raj, Sowjanya Aloori
13 [GO] 2021―Dec―20 Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis Hideyuki Negoro, Christos Chatziantonio, Mohammed S. Razzaque
14 [GO] 2021―Dec―13 Antimicrobial consumption in patients with COVID-19: A systematic review and meta-analysis Sidra Khan, Syed Shahzad Hasan, Stuart E. Bond, Barbara R Conway, Mamoon A. Aldayeb
15 [GO] 2021―Dec―13 Ivermectin: a pathway out of the pandemic or another dead end? Daniel Echeverría-Esnal, Santiago Grau
16 [GO] 2021―Dec―04 Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 infection among healthcare workers: a prospective cohort study Akshay Rao, Sundar Kumar Veluswamy, Banashankari Gunjiganur Shankarappa, Rithika Manjunatha Reddy, Nethravathi Umesh, Lissy John, et al. (+2)
17 [GO] 2021―Dec―02 Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review Paraskevas Filippidis, Julien Vionnet, Oriol Manuel, Matteo Mombelli
18 [GO] 2021―Nov―30 Evaluation of favipiravir in the treatment of COVID-19 based on the real-world Weishang Deng, Changyuan Yang, Sensen Yang, Haitao Chen, Zhikun Qiu, Jisheng Chen
19 [GO] 2021―Nov―19 Ethical challenges of prospective clinical trials during the COVID-19 pandemic Madison S. McCarthy, Matthew W. McCarthy
20 [GO] 2021―Nov―10 Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study Mehdi Azizmohammad Looha, Mostafa Rezaei-Tavirani, Mohammad Rostami-Nejad, Shahriar Janbazi, Elaheh Zarean, Payam Amini, et al. (+8)
21 [GO] 2021―Nov―06 Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials Shao-Huan Lan, Chiung-Kai Wang, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung, Wei-Ting Lin
22 [GO] 2021―Nov―06 Clinical efficacy and safety of interferon-β-containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Wang-Chun Chen, Chi-Kuei Hsu, Ching-Yi Chen, Chih-Cheng Lai, Shun-Hsing Hung, Wei-Ting Lin
23 [GO] 2021―Oct―30 Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials Chia Siang Kow, Amaan Javed, Dinesh Ramachandram, Syed Shahzad Hasan
24 [GO] 2021―Oct―30 Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics? Anatoly Mayburd
25 [GO] 2021―Oct―25 Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Abolfazl Akbari, Mahya Razmi, Alireza Sedaghat, Seyyed Mohammad Matin Alavi Dana, Mahdi Amiri, Ali Mohammad Halvani, et al. (+2)
26 [GO] 2021―Oct―13 Indomethacin: An exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19 Nishant Shekhar, Harpinder Kaur, Phulen Sarma, Ajay Prakash, Bikash Medhi
27 [GO] 2021―Oct―07 Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box Stefan Biendl, Cécile Häberli, Jennifer Keiser
28 [GO] 2021―Sep―20 Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis Ronal Yosua Limen, Rudyanto Sedono, Adhrie Sugiarto, Timotius Ivan Hariyanto
29 [GO] 2021―Sep―03 Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition Nihad Adnan, Shahad Saif Khandker, Ahsanul Haq, Mousumi Akter Chaity, Abdul Khalek, Anawarul Quader Nazim, et al. (+9)
30 [GO] 2021―Aug―06 The effects of the pandemic in cases of heart failure Gustavo Teixeira Bristot, Nikolas de Vargas Raupp, Eliane Mazzuco dos Santos, Elonir Gomes
31 [GO] 2021―Aug―04 Anti-inflammatory Effects of GLP-1 in Patients with COVID-19 Saharnaz Sazgarnejad, Niloufar Yazdanpanah, Nima Rezaei
32 [GO] 2021―Aug―03 Cardiovascular complications of COVID-19: towards better understanding, diagnosis, monitoring and management Marco Vicenzi, Massimiliano Ruscica, Tannaz Jamialahmadi, Amirhossein Sahebkar
33 [GO] 2021―Jul―29 Antiviral drugs for coronavirus disease 2019 (COVID-19): A systematic review with network meta-analysis George Okoli, Rasheda Rabbani, Amenah Al-Juboori, Leslie Copstein, Nicole Askin, Ahmed M. Abou-Setta
34 [GO] 2021―Jul―26 The rise of Mucormycosis in Covid-19 patients in India Migresh Bhatia
35 [GO] 2021―Jul―06 Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study Mahmoud El-Bendary, Sherief abd-elsalam, Tamer Elbaz, Wafaa El-Akel, Ahmed Cordie, Tamer Elhadidy, et al. (+11)
36 [GO] 2021―Jul―06 Molecular Detections of Coronavirus: Current and Emerging Methodologies Mingkun Diao, Lang Lang, Juan Feng, Rongsong Li
37 [GO] 2021―Jun―30 The use of remdesivir for the management of patients with moderate-to-severe COVID-19: A systematic review Kaeshaelya Thiruchelvam, Chia Siang Kow, Muhammad Hadi, Syed Shahzad Hasan
38 [GO] 2021―Jun―19 Diagnosis, prevention, and treatment of coronavirus disease: a review Manoj Kumar Sarangi, Sasmita Padhi, Shrivardhan Dheeman, Santosh Kumar Karn, L. D. Patel, Dong Kee Yi, Sitansu Sekhar Nanda
39 [GO] 2021―Jun―11 Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy Sadaf Jamal Gilani, May Bin-Jumah, Muhammad Shahid Nadeem, Imran Kazmi
40 [GO] 2021―Jun―05 NSAIDs/Nitazoxanide/Azithromycin Repurposed for COVID-19: Potential Mitigation of the Cytokine Storm Interleukin-6 Amplifier via Immunomodulatory Effects Mina T. Kelleni
41 [GO] 2021―May―21 Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice Radu Crisan Dabija, Ileana Antohe, Antigona Trofor, Sabina A Antoniu
42 [GO] 2021―Apr―16 Lifestle and rehabilitation during the COVID-19 pandemic: guidance for health professionals and support for exercise and rehabilitation programs Cássia da Luz Goulart, Rebeca Nunes Silva, Murilo Rezende Oliveira, Solange Guizilini, Isadora Salvador Rocco, Vanessa Marques Ferreira Mendez, et al. (+4)
43 [GO] 2021―Apr―12 Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2 Masoumeh Sadat Mousavi Maleki, Mosayeb Restamian, Hamid Madanchi
44 [GO] 2021―Apr―09 Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management Shreya R. Savla, Kedar S. Prabhavalkar, Lokesh K. Bhatt
45 [GO] 2021―Mar―30 System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: Preliminary experience of a tertiary care institute in India Praveen Kumar-M, Ritin Mohindra, Ashish Balla, Nusrat Shafiq, Vikas Suri, Deepa Kumari, et al. (+6)
46 [GO] 2021―Mar―24 Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: An observational prospective open label user survey Klang Shmuel, Megiddo Dalia, Lapidot Tair, Naparstek Yaakov
47 [GO] 2021―Mar―19 Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits Anindita Banerjee, Upasana Ganguly, Sarama Saha, Suddhachitta Chakrabarti, Reena V Saini, Ravindra K Rawal, et al. (+2)
48 [GO] 2021―Mar―15 Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials Nida Bokharee, Yusra Habib Khan, Aisha Khokhar, Tauqeer Hussain Mallhi, Nasser Hadal Alotaibi, Maria Rasheed
49 [GO] 2021―Mar―08 The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives Massimo Andreoni, Matteo Bassetti, Salvatore Corrao, Francesco Giuseppe De Rosa, Vincenzo Esposito, Marco Falcone, et al. (+6)
50 [GO] 2021―Feb―23 COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention Ashif Iqubal, Mohammad Kashif Iqubal, Farazul Hoda, Abul Kalam Najmi, Syed Ehtaishamul Haque
51 [GO] 2021―Jan―15 Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children Mohammad Zarei, Deepanwita Bose, Soheila Ali Akbari Ghavimi, Masoud Nouri-Vaskeh, Mehdi Mohammadi, Amirhossein Sahebkar
52 [GO] 2020―Dec―29 A review on favipiravir: the properties, function, and usefulness to treat COVID-19 Seyed MohammadReza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati
53 [GO] 2020―Dec―23 Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress Md. Jamal Hossain, S. M. Abdur Rahman
54 [GO] 2020―Dec―16 Exacerbation of antimicrobial resistance: another casualty of the covid-19 pandemic? Mohammed S. Razzaque
55 [GO] 2020―Dec―16 Potential Effectiveness and Adverse Implications of Repurposing Doxycycline in COVID-19 Treatment Lekshmi Narendrakumar, Iype Joseph, Sabu Thomas
56 [GO] 2020―Dec―14 The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies Zahra Payandeh, Niloufar Mohammad Khani, Mohsen Nabbi, Saeed Khalili, Masoumeh Rajabibazl, Zahra Houjaghani, Masoomeh Dadkhah
57 [GO] 2020―Dec―12 An Update on COVID-19 Pandemic: The Epidemiology, Pathogenesis, Prevention and Treatment Strategies Hin Fung Tsang, Lawrence Wing Chi Chan, William Chi Shing Cho, Allen Chi Shing Yu, Aldrin Kay Yuen Yim, Amanda Kit Ching Chan, et al. (+5)
58 [GO] 2020―Dec―03 Recent progress in the repurposing of drugs/molecules for the management of COVID-19 Divakar Sharma, Adinarayana Kunamneni
59 [GO] 2020―Nov―17 COVID-19 and inhibitors of the renin-angiotensin-aldosterone system Musaddique Hussain, Qaiser Jabeen, Fiaz-ud-Din Ahmad, Mobeen Fatima, Saira Shaukat, Abdul Majeed, et al. (+2)
60 [GO] 2020―Nov―14 Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review Betsy Ann Joseph, Mahmoud Dibas, Kirk W. Evanson, Geeta Paranjape, Charan Thej Reddy Vegivinti, Pragadeesh Thamarai Selvan, et al. (+15)
61 [GO] 2020―Nov―13 Drug repurposing: new strategies for addressing COVID-19 outbreak Pravin Shende, Bhakti Khanolkar, R.S. Gaud
62 [GO] 2020―Nov―08 Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints Mahendra Rai, Shital Bonde, Alka Yadav, Yulia Plekhanova, Anatoly Reshetilov, Indarchand Gupta, et al. (+3)
63 [GO] 2020―Oct―13 Could bacteriophages be the answer to the COVID-19 crisis? Antal Martinecz, Marcin W. Wojewodzic
64 [GO] 2020―Oct―12 Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease Stuti Bhagat, Nisha Yadav, Juhi Shah, Harsh Dave, Shachee Swaraj, Shashank Tripathi, Sanjay Singh
65 [GO] 2020―Sep―14 COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment and follow up Amir Tajbakhsh, Seyed Mohammad Gheibi hayat, Hajar Taghizadeh, Ali Akbari, Masoumeh Einabadi, Amir Savardashtaki, et al. (+2)
66 [GO] 2020―Sep―12 The effect of antivirals on COVID-19: a systematic review Nafisa Hussain, Anusha Yoganathan, Savini Hewage, Samiha Alom, Amer Harky
67 [GO] 2020―Aug―27 Azithromycin in the treatment of COVID-19: a review Daniel Echeverría-Esnal, Clara Martin-Ontiyuelo, María Eugenia Navarrete-Rouco, Marta De-Antonio Cuscó, Olivia Ferrández, Juan Pablo Horcajada, Santiago Grau
68 [GO] 2020―Aug―20 COVID-19: fighting the invisible enemy with microRNA Neeraj Chauhan, Meena Jaggi, Subhash C. Chauhan, Murali M. Yallapu
69 [GO] 2020―Aug―19 MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale Paul E. Marik, Pierre Kory, Joseph Varon, Jose Iglesias, G Umberto Meduri
70 [GO] 2020―Aug―04 Resolution of coronavirus disease 2019 (COVID-19) Khaled Habas, Chioma Nganwuchu, Fanila Shahzad, Rajendran Gopalan, Mainul Haque, Sayeeda Rahman, et al. (+2)
71 [GO] 2020―Jul―30 Call for proper documentation of COVID-19 deaths in poor resource setting: a necessity for management of future occurrences Ahoma V Mbanuzuru, Chukwuemeka C Okoro, Chinyere M Mbanuzuru, Christian C Ibeh
72 [GO] 2020―Jul―24 Integrative role of traditional and modern technologies to combat COVID-19 Mohammad Heiat, Mohammad-Reza Hashemi-Aghdam, Fatemeh Heiat, Mona Rastegar Shariat Panahi, Hossein Aghamollei, Mehrdad Moosazadeh Moghaddam, et al. (+3)
73 [GO] 2020―Jul―22 Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection Marco Infante, Camillo Ricordi, Rodolfo Alejandro, Massimiliano Caprio, Andrea Fabbri
74 [GO] 2020―Jul―22 Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study Krzysztof Tomasiewicz, Anna Piekarska, Justyna Stempkowska-Rejek, Sylwia Serafińska, Aleksandra Gawkowska, Miłosz Parczewski, et al. (+6)
75 [GO] 2020―Jul―16 Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends George Cherry, John Rocke, Michael Chu, Jacklyn Liu, Matt Lechner, Valerie J. Lund, B. Nirmal Kumar
76 [GO] 2020―Jul―14 The Use of IV vitamin C for patients with COVID-19: a single center observational study Raul Hiedra, Kevin Bryan Lo, Mohammad Elbashabsheh, Fahad Gul, Robert Matthew Wright, Jeri Albano, et al. (+2)
77 [GO] 2020―Jul―07 Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine; from HIV-1 infection to COVID-19 Sara Naghipour, Mahsa Ghodousi, Sara Rahsepar, Sepideh Elyasi
78 [GO] 2020―Jun―23 Can nanotechnology help in the fight against COVID-19? Gabriela Palestino, Ileana García-Silva, Omar González-Ortega, Sergio Rosales-Mendoza
79 [GO] 2020―Jun―17 Repurposing minocycline for COVID-19 management: mechanisms, opportunities and challenges Harmanjit Singh, Ashish Kumar Kakkar, Prerna Chauhan
80 [GO] 2020―Jun―14 Possible therapeutic agents for COVID-19: a comprehensive review Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay, Mohamed Gomaa Kamel
81 [GO] 2020―May―18 Old and re-purposed drugs for the treatment of COVID-19 Shio-Shin Jean, Po-Ren Hsueh
82 [GO] 2020―May―04 Quadruple therapy for asymptomatic COVID-19 infection patients Ling Wang, Xiaopeng Xu, Junshan Ruan, Saijin Lin, Jinhua Jiang, Hong Ye
83 [GO] 2020―Mar―29 How could artificial intelligence aid in the fight against coronavirus? Hadi M Yassine, Zubair Shah
 [1] 

83 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec